Selection and Persistence of CTX-M-Producing Escherichia coli in the Intestinal Flora of Pigs Treated with Amoxicillin, Ceftiofur, or Cefquinome
- 1 October 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (10) , 3612-3616
- https://doi.org/10.1128/aac.00354-08
Abstract
Extended-spectrum beta-lactamases (ESBLs), mainly of the CTX-M family, have been associated with Escherichia coli strains of animal origin in Europe. An in vivo experiment was performed to study the effects of veterinary beta-lactam drugs on the selection and persistence of ESBL-producing E. coli in the intestinal flora of pigs. Twenty pigs were randomly allocated into three treatment groups and one control group. All pigs were inoculated intragastrically with 10(10) CFU of a nalidixic acid (NAL)-resistant mutant derived from a CTX-M-1-producing E. coli strain of pig origin. Treatment with amoxicillin, ceftiofur, or cefquinome according to the instructions on the product label was initiated immediately after bacterial inoculation. Feces were collected from the rectum before inoculation and on days 4, 8, 15, 22, and 25 after the start of treatment. The total and resistant coliforms were counted on MacConkey agar with and without cefotaxime (CTX). Furthermore, MacConkey agar with CTX and NAL was used to count the number of CFU of the inoculated strain. Significantly higher counts of CTX-resistant coliforms were observed in the three treatment groups than in the control group for up to 22 days after the discontinuation of treatment. Ceftiofur and cefquinome exerted larger selective effects than amoxicillin, and the effects persisted beyond the withdrawal times recommended for these cephalosporins. The inoculated strain was detected in only nine animals on day 25. The increase in the number of CTX-resistant coliforms was mainly due to the proliferation of indigenous CTX-M-producing strains and the possible emergence of strains that acquired CTX-M genes by horizontal transfer. The study provides evidence that the cephalosporins used in pig production select for CTX-M-producing E. coli strains. Their use in animals should be carefully considered in view of the critical importance of cephalosporins and the zoonotic potential of ESBL-producing bacteria.Keywords
This publication has 19 references indexed in Scilit:
- Guidelines for Antimicrobial Use in SwinePublished by Wiley ,2008
- Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofurJournal of Antimicrobial Chemotherapy, 2007
- CTX-M: changing the face of ESBLs in EuropeJournal of Antimicrobial Chemotherapy, 2006
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food productionJournal of Antimicrobial Chemotherapy, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The NetherlandsJournal of Antimicrobial Chemotherapy, 2005
- Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pigJournal of Antimicrobial Chemotherapy, 2004
- Detection of CMY-2, CTX-M-14, and SHV-12 β-Lactamases in Escherichia coli Fecal-Sample Isolates from Healthy ChickensAntimicrobial Agents and Chemotherapy, 2003